201 related articles for article (PubMed ID: 35726432)
1.
Gul A; Saad SM; Zafar H; Atia-Tul-Wahab ; Khan KM; Choudhary MI
Med Chem; 2023; 19(4):384-392. PubMed ID: 35726432
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, molecular docking and xanthine oxidase inhibitory activity of 5-aryl-1H-tetrazoles.
Fatima I; Zafar H; Khan KM; Saad SM; Javaid S; Perveen S; Choudhary MI
Bioorg Chem; 2018 Sep; 79():201-211. PubMed ID: 29772470
[TBL] [Abstract][Full Text] [Related]
3. Xanthine Oxidase Inhibitory and Molecular Docking Studies on Pyrimidones.
Zafar H; Iqbal S; Javaid S; Khan KM; Choudhary MI
Med Chem; 2018; 14(5):524-535. PubMed ID: 29189174
[TBL] [Abstract][Full Text] [Related]
4.
Mehmood A; Rehman AU; Ishaq M; Zhao L; Li J; Usman M; Zhao L; Rehman A; Zad OD; Wang C
Comb Chem High Throughput Screen; 2020; 23(9):917-930. PubMed ID: 32342806
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of N-(3-cyano-1H-indol-5/6-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamides and 5-(6-oxo-1,6-dihydropyrimidin-2-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors.
Zhang B; Duan Y; Yang Y; Mao Q; Lin F; Gao J; Dai X; Zhang P; Li Q; Li J; Dai R; Wang S
Eur J Med Chem; 2022 Jan; 227():113928. PubMed ID: 34688012
[TBL] [Abstract][Full Text] [Related]
6. Xanthine oxidase inhibitory activity of nicotino/isonicotinohydrazides: A systematic approach from in vitro, in silico to in vivo studies.
Zafar H; Hayat M; Saied S; Khan M; Salar U; Malik R; Choudhary MI; Khan KM
Bioorg Med Chem; 2017 Apr; 25(8):2351-2371. PubMed ID: 28302506
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of 1-alkyl-5/6-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors.
Gao J; Liu X; Zhang B; Mao Q; Zhang Z; Zou Q; Dai X; Wang S
Eur J Med Chem; 2020 Mar; 190():112077. PubMed ID: 32014678
[TBL] [Abstract][Full Text] [Related]
8. In vitro xanthine oxidase inhibitory and in vivo anti-hyperuricemic properties of sodium kaempferol-3'-sulfonate.
Wang X; Cui Z; Luo Y; Huang Y; Yang X
Food Chem Toxicol; 2023 Jul; 177():113854. PubMed ID: 37230458
[TBL] [Abstract][Full Text] [Related]
9. Computational Analysis and Synthesis of Syringic Acid Derivatives as Xanthine Oxidase Inhibitors.
Malik N; Khatkar A; Dhiman P
Med Chem; 2020; 16(5):643-653. PubMed ID: 31584375
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of hydroxychalcones as multifunctional non-purine xanthine oxidase inhibitors for the treatment of hyperuricemia.
Xie Z; Luo X; Zou Z; Zhang X; Huang F; Li R; Liao S; Liu Y
Bioorg Med Chem Lett; 2017 Aug; 27(15):3602-3606. PubMed ID: 28655421
[TBL] [Abstract][Full Text] [Related]
11. Chalcone derivatives as xanthine oxidase inhibitors: synthesis, binding mode investigation, biological evaluation, and ADMET prediction.
Yang C; Liu Y; Tu Y; Li L; Du J; Yu D; He P; Wang T; Liu Y; Chen H; Li Y
Bioorg Chem; 2023 Feb; 131():106320. PubMed ID: 36527991
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Xanthine Oxidase by 4-nitrocinnamic Acid:
Chen J; Yu S; He Z; Zhu D; Cai X; Ruan Z; Jin N
Curr Pharm Biotechnol; 2024; 25(4):477-487. PubMed ID: 37345239
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of thiazolidine-2-thione derivatives as novel xanthine oxidase inhibitors.
Wang MX; Qin HW; Liu C; Lv SM; Chen JS; Wang CG; Chen YY; Wang JW; Sun JY; Liao ZX
PLoS One; 2022; 17(5):e0268531. PubMed ID: 35584139
[TBL] [Abstract][Full Text] [Related]
14. Identification of natural xanthine oxidase inhibitors: Virtual screening, anti-xanthine oxidase activity, and interaction mechanism.
Yu D; Du J; He P; Wang N; Li L; Liu Y; Yang C; Xu H; Li Y
Int J Biol Macromol; 2024 Feb; 259(Pt 2):129286. PubMed ID: 38216015
[TBL] [Abstract][Full Text] [Related]
15. Novel 3-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-1,2,4-oxadiazol-5(4H)-ones as promising xanthine oxidase inhibitors: Design, synthesis and biological evaluation.
Gao J; Zhang Z; Zhang B; Mao Q; Dai X; Zou Q; Lei Y; Feng Y; Wang S
Bioorg Chem; 2020 Jan; 95():103564. PubMed ID: 31927335
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of 5-(1H-indol-5-yl)isoxazole-3-carboxylic acids as novel xanthine oxidase inhibitors.
Huang D; Li W; Zhao Y; Xie C; Luo X; Wu F; Xu Z; Sun Q; Liu G
Eur J Med Chem; 2024 May; 271():116443. PubMed ID: 38691887
[TBL] [Abstract][Full Text] [Related]
17. Novel xanthine oxidase inhibitory peptides derived from whey protein: identification, in vitro inhibition mechanism and in vivo activity validation.
Qi X; Chen H; Guan K; Sun Y; Wang R; Li Q; Ma Y
Bioorg Chem; 2022 Nov; 128():106097. PubMed ID: 35985156
[TBL] [Abstract][Full Text] [Related]
18. Xanthine oxidase inhibitory peptides derived from tuna protein: virtual screening, inhibitory activity, and molecular mechanisms.
Yu Z; Kan R; Wu S; Guo H; Zhao W; Ding L; Zheng F; Liu J
J Sci Food Agric; 2021 Mar; 101(4):1349-1354. PubMed ID: 32820534
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, structure-activity relationships, and mechanistic studies of 5-arylazo-tropolone derivatives as novel xanthine oxidase (XO) inhibitors.
Sato D; Kisen T; Kumagai M; Ohta K
Bioorg Med Chem; 2018 Jan; 26(2):536-542. PubMed ID: 29274704
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, biological evaluation of 3,5-diaryl-4,5-dihydro-1H-pyrazole carbaldehydes as non-purine xanthine oxidase inhibitors: Tracing the anticancer mechanism via xanthine oxidase inhibition.
Joshi G; Sharma M; Kalra S; Gavande NS; Singh S; Kumar R
Bioorg Chem; 2021 Feb; 107():104620. PubMed ID: 33454509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
